Sanofi - ADR

Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry

A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More

Could Investors Overdose on Pharmaceuticals?

IGM Biosciences Raises $200 Million After Announcing Sanofi Collaboration

Adagene Partners With Sanofi in Biobucks Deal Worth Up to $2.5 Billion